Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apoptosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07601685
What this trial is testing

MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study)

Who this might be right for
PeriodontitisGingivitis and Periodontal DiseasesBiomarker Discovery and Validation+1 more
Inonu University 48
Early research (Phase 1)Study completedNCT04223804
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV InfectionHIV-1
AbbVie 41
Large-scale testing (Phase 3)Ended earlyNCT00215943
What this trial is testing

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 90
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Large-scale testing (Phase 3)WithdrawnNCT03744247
What this trial is testing

Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT04669899
What this trial is testing

Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626518
What this trial is testing

Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 370
Not applicableUnknownNCT01442350
What this trial is testing

Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers

Who this might be right for
Fabry Disease, Cardiac VariantRight Ventricular Hypertrophy
Francisco Marín Ortuño 120
Early research (Phase 1)Study completedNCT01383733
What this trial is testing

RO5458640 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 54
Not applicableUnknownNCT02102659
What this trial is testing

Biological Assessment of Clinical Nutrition and Its Application

Who this might be right for
Malnutrition
Huazhong University of Science and Technology 167
Not applicableUnknownNCT00172588
What this trial is testing

Evaluation of Endometrial Stromal Cell Apoptosis in Adenomyosis

Who this might be right for
Endometriosis
National Taiwan University Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04895358
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 342
Testing effectiveness (Phase 2)Looking for participantsNCT06961006
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Who this might be right for
Malignant Melanoma
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Ended earlyNCT04152863
What this trial is testing

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Who this might be right for
Advanced/Metastatic Melanoma
Merck Sharp & Dohme LLC 85
Testing effectiveness (Phase 2)Ended earlyNCT04643405
What this trial is testing

APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic Cancer
Ascentage Pharma Group Inc. 21
Not applicableStudy completedNCT05432622
What this trial is testing

Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)Study completedNCT03322566
What this trial is testing

Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Who this might be right for
Lung Cancer
Incyte Corporation 233
Large-scale testing (Phase 3)Study completedNCT04221945
What this trial is testing

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

Who this might be right for
Uterine Cervical Neoplasms
Merck Sharp & Dohme LLC 1,060
Not applicableStudy completedNCT02526732
What this trial is testing

Hepatic Inflammation and Physical Performance in Patients With NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
Priv.-Doz. Dr. J. Schattenberg 44
Next Page